Role of important protein improves understanding of autoimmune diseases

22 Mar 2016, 4:59 p.m.

Genetic analyser for BRC

Researchers – led by Great Ormond Street BRC-supported Professor Tessa Crompton in collaboration with the Paediatric Department at Oxford University – have identified the role of a key protein in normal development of the thymus, an important organ of the immune system. The protein, known as Sonic hedgehog (SHH), is one of a few factors that regulate thymic epilthelial cell (TEC) differentiation and lineage choice. These findings contribute to our understanding of human autoimmune diseases and will inform strategies to replace thymus function in athymic children.

TECs are an essential component of the thymic stroma and are required to support T cell development. Two broad categories of TEC exist; medullary TECs, which are essential for the induction of tolerance to self, and cortical TECs, which are essential for T cell fate specification and T cell receptor repertoire selection. Researchers used both adult and foetal TECs to show that SHH regulates medullary TEC differentiation and function, with the potential to alter central tolerance.

These findings are important to our understanding of immunity, autoimmunity and immunodeficiency. In the future it will be important to assess the effects of SHH signalling on the induction and severity of human autoimmune diseases.

These findings were published in the Journal of Autoimmunity.

NIHR launches £13.7m investment into brain tumour research

The National Institute for Health and Care Research (NIHR) has announced a £13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.

New consortium aims to help improve care for arthritis patients

A new UK-led research group, including Great Ormond Street Hospital and University College London, aims to improve the lives of children, young people and adults with arthritis by defining for the first time what being in ‘remission’ from arthritis truly

Update for patients and families on industrial action - December 2025

As you may be aware, some of our Resident Doctors will be taking part in planned industrial action from 7am on Wednesday 17 December to 7am on Monday 22 December.

‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-Cell leukaemia

A groundbreaking new treatment using gene-edited immune cells, developed at GOSH and UCL has shown promising results in helping children and adults fight a rare and aggressive cancer